A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease

Cited by (217)

Items 101–200 of 217

1. New Insights into how HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection
   Peter A. Revill, Zhenghong Yuan · 2013 · Antiviral Therapy
2. Chromofungin (CHR: CHGA47–66) is downregulated in persons with active ulcerative colitis and suppresses pro‐inflammatory macrophage function through the inhibition of NF‐&kgr;B signaling
   N. Eissa, Hayam A Hussein, Laëtitia Kermarrec, Omar Elgazzar, M. Metz-Boutigue, C. Bernstein, J. Ghia · 2017 · Biochemical Pharmacology
3. Inhibition of TLR4 signalling to dampen joint inflammation in osteoarthritis
   Yvonne L Bartels, Peter L. E. M. van Lent, Peter M. van der Kraan, Arjen B. Blom, Kimberly M. Bonger, Martijn H. J. van den Bosch · 2023 · Lara D. Veeken
4. TLR4-IN-C34 Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses via Downregulating TLR4/MyD88/NF-κB/NLRP3 Signaling Pathway and Reducing ROS Generation in BV2 Cells
   Shanshan Zhang, Man Liu, Dong-Ni Liu, Yinglin Yang, Guanhua Du, Yuehua Wang · 2021 · Inflammation
5. Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants
   Aurelia Magdalena Pisoschi, Florin Iordache, Loredana Stanca, Carmen Laura Cimpeanu, Florin Furnaris, Ovidiu Ionuț Geicu, Liviu Bîlteanu, Andreea Iren Șerban · 2023 · European Journal of Medicinal Chemistry
6. Characterization of Dextran Sodium Sulfate-Induced Inflammation and Colonic Tumorigenesis in Smad3−/− Mice with Dysregulated TGFβ
   Audrey Seamons, Piper M. Treuting, Thea Brabb, Lillian Maggio‐Price · 2013 · PLoS ONE
7. T oll‐like receptors in hepatitis C infection: Implications for pathogenesis and treatment
   Jessica A. Howell, Peter Angus, Paul John Gow, Kumar Visvanathan · 2013 · Journal of Gastroenterology and Hepatology
8. Effects of probiotics on Toll-like receptor expression in ulcerative colitis rats induced by 2,4,6-trinitro-benzene sulfonic acid
   Ping Yao, Fang Tan, Hongliang Gao, Lei Wang, Tao Yang, Yongbo Cheng · 2017 · Molecular Medicine Reports
9. Anti-inflammation of Erianin in dextran sulphate sodium-induced ulcerative colitis mice model via collaborative regulation of TLR4 and STAT3
   Bo Dou, Wenji Hu, Minkai Song, Robert J. Lee, Xiaoyu Zhang, Di Wang · 2020 · Chemico-Biological Interactions
10. Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease
    Daniele Corridoni, Thomas Chapman, Tim Ambrose, Alison Simmons · 2018 · Frontiers in Medicine
11. Bacterial colonization, probiotics, and clinical disease
    Meiqian Weng, W. Allan Walker · 2006 · The Journal of Pediatrics
12. Role of Gut Microbiota in a Zebrafish Model with Chemically Induced Enterocolitis Involving Toll-Like Receptor Signaling Pathways
    Qi He, Lin Wang, Fan Wang, Qiurong Li · 2014 · Zebrafish
13. RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146
    Yoshinori Matsumoto, José LaRose, Oliver A. Kent, Melissa Lim, Adele Changoor, Lucia Zhang, Yaryna Storozhuk, Xiaohong Mao, Marc D. Grynpas, Feng Cong et al. · 2017 · Journal of Clinical Investigation
14. Therapeutic impact of toll-like receptors on inflammatory bowel diseases: A multiple-edged sword
    Elke Cario · 2007 · Inflammatory Bowel Diseases
15. Targeting Toll-like Receptors in Autoimmunity
    Kim S. Midwood, Anna Maria Piccinini, Sandra M. Sacre · 2009 · Current Drug Targets
16. miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation
    Sigrid E.M. Heinsbroek, Mario Leonardo Squadrito, Ronald Schilderink, Francisca W. Hilbers, Caroline Verseijden, Majella‐Sophie Hofmann, Alexandra Helmke, Louis Boon, Manon E. Wildenberg, Joris J. T. H. Roelofs et al. · 2015 · Mucosal Immunology
17. TRIF Modulates TLR5-dependent Responses by Inducing Proteolytic Degradation of TLR5
    Yoon Jeong Choi, Eunok Im, Charalabos Pothoulakis, Sang Hoon Rhee · 2010 · Journal of Biological Chemistry
18. Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer
    Vinita Mishra, Chandramani Pathak · 2018 · International Journal of Biological Macromolecules
19. The effect of immunomodulatory properties of naringenin on the inhibition of inflammation and oxidative stress in autoimmune disease models: a systematic review and meta-analysis of preclinical evidence
    Mina Alimohammadi, Rebar N. Mohammad, Ali Akbar Rahim Rahimi, Fatemeh Faramarzi, Reza Alizadeh‐Navaei, Alireza Rafiei · 2022 · Inflammation Research
20. β-1,4-Mannobiose Stimulates Innate Immune Responses and Induces TLR4-Dependent Activation of Mouse Macrophages but Reduces Severity of Inflammation during Endotoxemia in Mice
    Jennifer Kovacs-Nolan, Hiroyuki Kanatani, Akihiro Nakamura, Masahisa Ibuki, Yoshinori Mine · 2013 · Journal of Nutrition
21. C-glycosyl flavonoid orientin improves chemically induced inflammatory bowel disease in mice
    Aning Sun, Gaiyan Ren, Chao Deng, Jingjing Zhang, Xiaoping Luo, Xiaojun Wu, Sridhar Mani, Wei Dou, Zhengtao Wang · 2016 · Journal of Functional Foods
22. Necrotizing Enterocolitis: LPS/TLR4-Induced Crosstalk Between Canonical TGF-β/Wnt/β-Catenin Pathways and PPARγ
    Alexia Gomart, Alexandre Vallée, Yves Lecarpentier · 2021 · Frontiers in Pediatrics
23. Severe sepsis and Toll-like receptors
    Hongmei Gao, Susannah K. Leaver, Anne C. Burke-Gaffney, Simon J. Finney · 2007 · Seminars in Immunopathology
24. Toll‐Like Receptor Signaling and its Relevance to Intestinal Inflammation
    Elke Cario, Daniel K. Podolsky · 2006 · Annals of the New York Academy of Sciences
25. Theabrownin from Pu-erh Tea Improves DSS-Induced Colitis via Restoring Gut Homeostasis and Inhibiting TLR2&4 Signaling Pathway
    Lei Zhao, Chunyan Zhao, Yue Miao, Shuwen Lei, Yujing Li, Jiashun Gong, Chunxiu Peng · 2024 · Phytomedicine
26. Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles
    Valentina Calabrese, Roberto Cighetti, Francesco Peri · 2014 · Molecular Immunology
27. TLR4 monoclonal antibody blockade suppresses dextran‐sulfate‐sodium‐induced colitis in mice
    Yi Liu, Zhijun Zhang, Lei Wang, Juan Li, Le Dong, Wenjie Yue, Jian Chen, Xu Sun, Liang Zhong, Dayu Sun · 2009 · Journal of Gastroenterology and Hepatology
28. Worms, flies and four-legged friends: the applicability of biological models to the understanding of intestinal inflammatory diseases
    Joyce Lin, David Joel Hackam · 2011 · Disease Models & Mechanisms
29. Dapsone reduced acetic acid-induced inflammatory response in rat colon tissue through inhibition of NF-kB signaling pathway
    Amir Rashidian, Asma Rashki, Alireza Abdollahi, Nazgol‐Sadat Haddadi, Mohsen Chamanara, Faiza Mumtaz, Ahmad Reza Dehpour · 2019 · Immunopharmacology and Immunotoxicology
30. The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes
    Maziar Gooshe, Amir Hossein Abdolghaffari, Maria Elsa Gambuzza, Nima Rezaei · 2014 · Reviews in the Neurosciences
31. Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties
    Florent Cochet, Fabio Alessandro Facchini, Lenny Zaffaroni, Jean‐Marc Billod, Helena Coelho, Aurora Holgado, Harald Braun, Rudi Beyaert, Roman Jerala, Jesús Jiménez‐Barbero et al. · 2019 · Scientific Reports
32. Vizantin Inhibits Endotoxin-Mediated Immune Responses via the TLR 4/MD-2 Complex
    Masataka Oda, Hirofumi Yamamoto, Masahiro Shibutani, Mayo Nakano, Kenta Yabiku, Takafumi Tarui, Naoya Kameyama, Daiki Shirakawa, Sumiyo Obayashi, Naoyuki Watanabe et al. · 2014 · The Journal of Immunology
33. Inhibition of NADPH Oxidase Activities Ameliorates DSS-Induced Colitis
    Tao Yu, Ping Wan, Xiaodan Zhu, Yuping Ren, Chong Wang, Runwei Yan, Yuan Guo, Aiping Bai · 2018 · Biochemical Pharmacology
34. TLR2‐independent induction and regulation of chronic intestinal inflammation
    Olivier Boulard, Mark J. Asquith, Fiona M. Powrie, Kevin Joseph Maloy · 2009 · European Journal of Immunology
35. DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma
    Chhinder P. Sodhi, Ryan M. Levy, Roop Gill, Matthew D. Neal, Ward M. Richardson, Maria F. Branca, Anthony M. Russo, Thomas Prindle, Timothy R. Billiar, David Joel Hackam · 2011 · American Journal of Physiology-Gastrointestinal and Liver Physiology
36. Ex-vivo generation of drug-eluting islets improves transplant outcomes by inhibiting TLR4-Mediated NFkB upregulation
    Charles Chang, Babatope Akinbobuyi, Jeremy M. Quintana, Gumpei Yoshimatsu, Bashoo Naziruddin, Robert R. Kane · 2017 · Biomaterials
37. Therapeutic effect of Brucea javanica oil emulsion on experimental Crohn’s disease in rats: Involvement of TLR4/ NF-κB signaling pathway
    Yanfeng Huang, Qiaoping Li, Yaoxing Dou, Tong-Tong Wang, Chang F. Qu, Jia-Li Liang, Zhi‐Xiu Lin, Xiaoqi Huang, Ziren Su, Jiannan Chen et al. · 2019 · Biomedicine & Pharmacotherapy
38. Toll-like Receptors and Thrombopoiesis
    Xiaoqin Tang, Qian Xu, Shuo Yang, Xinwu Huang, Long Wang, Feihong Huang, Jiesi Luo, Xiaogang Zhou, Anguo Wu, Qibing Mei et al. · 2023 · International Journal of Molecular Sciences
39. The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B
    Xiu-Qing Wei, Yunwei Guo, Jiajun Liu, Zhuo-Fu Wen, Yang Shao-ji, Yao Ji-lu · 2008 · Clinical and investigative medicine
40. The ‘Ethereal’ nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics
    Hélène G. Bazin, Tim J. Murray, William S. Bowen, Afsaneh Mozaffarian, Steven P. Fling, Laura S. Bess, Mark T. Livesay, Jeffrey S. Arnold, Craig L. Johnson, Kendal T. Ryter et al. · 2008 · Bioorganic & Medicinal Chemistry Letters
41. Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory
    Avi Levin, Oren Shibolet · 2008 · World Journal of Gastroenterology
42. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease
    Felix I. L. Clanchy, Sandra M. Sacre · 2010 · Expert Opinion on Biological Therapy
43. Signals Triggered by a Bacterial Pore-Forming Toxin Contribute to Toll-Like Receptor Redundancy in Gram-Positive Bacterial Recognition
    Nelson O. Gekara, Nicole L. Dietrich, Marcin Łyszkiewicz, Stefan Lienenklaus, Siegfried Weiß · 2008 · The Journal of Infectious Diseases
44. Acute kidney injury: a conspiracy of toll-like receptor 4 on endothelia, leukocytes, and tubules
    Christopher Y. Lu, Pamela D. Winterberg, Jianlin Chen, John R. Hartono · 2011 · Pediatric Nephrology
45. THE NOVEL SELECTIVE TOLL‐LIKE RECEPTOR 4 SIGNAL TRANSDUCTION INHIBITOR TAK‐242 PREVENTS ENDOTOXAEMIA IN CONSCIOUS GUINEA‐PIGS
    Masamune Kuno, Kayo Nemoto, Norifumi Ninomiya, Eiji Inagaki, Minoru Kubota, Tatsumi Matsumoto, Hiroyuki Yokota · 2009 · Clinical and Experimental Pharmacology and Physiology
46. Novel susceptibility genes in inflammatory bowel disease
    Colin L. Noble · 2006 · World Journal of Gastroenterology
47. Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson’s Disease
    Drobny, Alice, Ngo, Phuong A., Neurath, Markus F., Zunke, Friederike, López-Posadas, Rocío · 2021 · Frontiers in Medicine
48. Expression of Toll‐like receptor 4 in rat liver during the course of carbon tetrachloride‐induced liver injury
    Jing Hua, Dekai Qiu, Ji Qiang Li, Eng Ling LI, Xiao Yu Chen, Yan Sheng Peng · 2007 · Journal of Gastroenterology and Hepatology
49. Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma
    Naz Fatima, Tasleem Akhtar, Nadeem Sheikh · 2017 · Canadian Journal of Gastroenterology and Hepatology
50. Risperidone attenuates acetic acid-induced colitis in rats through inhibition of TLR4/NF-kB signaling pathway
    Hasan Yousefi‐Manesh, Pegah Dejban, Faiza Mumtaz, Alireza Abdollahi, Mohsen Chamanara, Ahmad Reza Dehpour, Amin Hasanvand, Amir Rashidian · 2020 · Immunopharmacology and Immunotoxicology
51. Gut-liver-axis microphysiological system for studying cellular fluidic shear stress and inter-tissue interaction
    Yang, Jiandong, Hirai, Yoshikazu, Imamura, Satoshi, Tsuchiya, Toshiyuki, Tabata, Osamu, Kamei, Ken-ichiro · 2022
52. Supplementation with postbiotic from Bifidobacterium Breve BB091109 improves inflammatory status and endocrine function in healthy females: a randomized, double-blind, placebo-controlled, parallel-groups study
    Diana Elena Motei, Beyda Beteri, Piril Hepsomali, George Tzortzis, Jelena Vulevic, Adele Costabile · 2023 · Frontiers in Microbiology
53. Toll-Like Receptor 4 Decoy, TOY, Attenuates Gram-Negative Bacterial Sepsis
    Keehoon Jung, Jung Eun Lee, Hak-Zoo Kim, Ho Min Kim, Beom Seok Park, Seong-Ik Hwang, Jie‐Oh Lee, Sun Chang Kim, Gou Young Koh · 2009 · PLoS ONE
54. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production
    Sprong, Tom, Ley, Peter van der, Abdollahi-Roodsaz, Shahla, Joosten, Leo, Meer, Jos van der, Netea, Mihai, Deuren, Marcel van · 2011 · Innate Immunity
55. Structural insights into pharmacophore-assistedin silicoidentification of protein–protein interaction inhibitors for inhibition of human toll-like receptor 4 – myeloid differentiation factor-2 (hTLR4−MD-2) complex
    Vinita Mishra, Chandramani Pathak · 2018 · Journal of Biomolecular Structure and Dynamics
56. Investigation of TLR4 Antagonists for Prevention of Intestinal Inflammation
    Janine S. Y. Tam, Janet K. Coller, Clive A. Prestidge, Joanne M. Bowen · 2022 · Inflammation
57. M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice
    Alexandra Vlk, Daniel Prantner, Kari Ann Shirey, Darren J. Perkins, Marguerite S. Buzza, Vivek Thumbigere‐Math, Achsah Dorsey Keegan, Stefanie N. Vogel · 2023 · mBio
58. Aberrant innate immune responses in TLR-ligand activated HLA-B27 transgenic rat cells
    Bi‐Feng Qian, Susan L. Tonkonogy, Ryan Balfour Sartor · 2008 · Inflammatory Bowel Diseases
59. TLR2 in murine atherosclerosis
    Peter S. Tobias, Linda K. Curtiss · 2007 · Seminars in Immunopathology
60. Toll-like receptor 4
    Ian Sabroe · 2010 · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research
61. HCC Is promoted by bacterial translocation and TLR-4 signaling: A new paradigm for chemoprevention and management
    Sara Toffanin, Helena Cornellà, Andrew Harrington, Josep Maria Llovet, Roberto J. Groszmann, Yasuko Iwakiri, Tamar Hamosh Taddei · 2012 · Hepatology
62. Current Status of Toll-Like Receptor 4 Ligand Vaccine Adjuvants
    Christopher B. Fox, Darrick Carter, Ryan M. Kramer, Anna Marie Beckmann, Steven G. Reed · 2017 · Elsevier eBooks
63. Novel synthetic gluco‐disaccharide RSCL‐0409 – a lipopolysaccharide‐induced Toll‐like receptor‐mediated signalling antagonist
    Mani Deepthi Kalluri, Praneel Datla, Akshaya Bellary, Khalander Basha, Ashwani Kumar Sharma, Anuradha Sharma, SHIVA PRATAP SINGH, Shakti N. Upadhyay, Vikram Rajagopal · 2010 · FEBS Journal
64. Guidelines for inflammation models in mice for food components
    Yanhui Han, Sasha A. Itenberg, Xian Wu, Hang Xiao · 2022 · eFood
65. Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021
    Tai Zhang, Beihua Zhang, Wende Tian, Fengyun Wang, Jiaqi Zhang, Xiangxue Ma, Yuchen Wei, Xudong Tang · 2022 · Frontiers in Pharmacology
66. Immune response modifiers: Imiquimod and future drugs for modulating the immune response
    Mark A. Tomai, Richard Lloyd Miller, Kenneth E. Lipson, John P. Vasilakos, Susan L. Woulfe · 2006 · Drug Discovery Today Therapeutic Strategies
67. Modulating LPS Signal Transduction at the LPS Receptor Complex with Synthetic Lipid A Analogues
    Aileen F. Bongat White, Alexei V. Demchenko · 2014 · Advances in carbohydrate chemistry and biochemistry
68. Tankyrase represses autoinflammation through the attenuation of TLR2 signaling
    Yoshinori Matsumoto, Ioannis D. Dimitriou, José La Rose, Melissa Lim, Susan Camilleri, Napoleon Law, Hibret A. Adissu, Jiefei Tong, Michael F. Moran, Andrzej J. Chruscinski et al. · 2022 · Journal of Clinical Investigation
69. Phenyl methimazole suppresses dextran sulfate sodium-induced murine colitis
    Uruguaysito Benavides, Mariana Gonzalez-Murguiondo, Norikazu Harii, Christopher John Lewis, Harshad S. Sakhalkar, Sudhir P. Deosarkar, David T. Kurjiaka, Nilesh M. Dagia, Douglas J. Goetz, Leonard D. Kohn · 2010 · European Journal of Pharmacology
70. Plugging the Leak in Dengue Shock
    Daniel Watterson, Naphak Modhiran, David Alexander Muller, Katryn J. Stacey, Paul R. Young · 2018 · Advances in experimental medicine and biology
71. Immune Interventions of Human Diseases through Toll-Like Receptors
    Cevayir Coban, Ken J. Ishii, Shizuo Akira · 2009 · Advances in experimental medicine and biology
72. Macrophage activation by gastric fluid suggests MMP involvement in aspiration-induced lung disease
    Chih-Mei Cheng, Chong Chao Hsieh, Chang Sheng Lin, Zen‐Kong Dai, Pin Keng Shih, Mary Lou Everett, Anitra D. Thomas, William Parker, R. Duane Davis, Shu S. Lin · 2009 · Immunobiology
73. Inhibitive effect of TAK-242 on Tenon’s capsule fibroblasts proliferation in rat eyes
    Liang Liang · 2019 · International Journal of Ophthalmology
74. Immunopharmacology of Lipid A Mimetics
    William S. Bowen, Siva K. Gandhapudi, Joseph P. Kolb, Thomas C. Mitchell · 2013 · Advances in pharmacology
75. Experimental TLR4 inhibition improves intestinal microcirculation in endotoxemic rats
    Juan Zhou, Marieke Soltow, Katrin Zimmermann, Dragan Pavlović, Brent Johnston, Christine Lehmann · 2015 · Microvascular Research
76. Taking its TOLL: the role of toll-like receptor 4 in human health and disease, and its potential as a therapeutic target
    Phoebe Crammond, Priyanka Hastak, Anthony P. Delaney, Sarah Christina Sasson · 2026 · Frontiers in Immunology
77. Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity
    Janine S. Y. Tam, Elise E. Crame, Aurelia S. Elz, Janet K. Coller, Anthony D. Wignall, Clive A. Prestidge, Joanne M. Bowen · 2022 · Cancer Chemotherapy and Pharmacology
78. Innate Immunity
    Lars Eckmann · 2006 · Elsevier eBooks
79. Antagonizing Toll-like Receptors to Prevent Preterm Labor
    Vikki M. Abrahams · 2008 · Reproductive Sciences
80. Is it possible to intervene early cirrhosis by targeting toll-like receptors to rebalance the intestinal microbiome?
    Jiaxin Zhang, Xiaobin Zao, Jiaying Zhang, Ziwei Guo, Qian Jin, Guang Chen, Danan Gan, Hongbo Du, Yongan Ye · 2022 · International Immunopharmacology
81. Benzenediamine analog FC-99 inhibits TLR2 and TLR4 signaling in peritoneal macrophage in vitro
    Liu Yang, Huan Dou, Yuxian Song, Yayi Hou · 2015 · Life Sciences
82. Sex differences in TLR4 expression in SHR do not contribute to sex differences in blood pressure or the renal T cell profile
    Kasey Belanger, Riyaz Mohamed, Robert Clinton Webb, Jennifer C. Sullivan · 2022 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
83. Maladie de Crohn et génétique: connaissances actuelles
    J. Lamoril, Jean‐Charles Deybach, P. Bouizegarène · 2007 · Immuno-analyse & Biologie Spécialisée
84. Neutrophil-Dependent Oxidative Stress in Inflammatory Gastrointestinal Diseases
    Yuji Naito, Toshikazu Yoshikawa · 2010 · Frontiers of gastrointestinal research
85. The microbiome role in pathogenesis of inflammatory and immune alterations of gastrointestinal tract in pediatric patients with cancer
    D. A. Morgacheva, Yu. V. Dinikina, Yu. K. Toshina, Margarita Borisovna Belogurova · 2021 · Oncohematology
86. Animal models of inflammatory bowel disease
    Sreekant Murthy · 2006 · Birkhäuser Basel eBooks
87. RETRACTED: Toll-like receptor 2/4 inhibitors can reduce preterm birth in mice
    Jing Xu, Min Chen, Liu Qi Yun, Hu Shun Qin, Li Rui, Jia Li, Ma Mei · 2020 · Journal of International Medical Research · Retracted
88. Chronic kidney disease: pathophysiological role of dysbiosis of intestine and renoprotective effectiveness of interventions concerning its modulation
    K.A. Aytbaev Aytbaev, Ilkhom T. Murkamilov, R.R. Kaliev Kaliev · 2016 · Russian Medicine
89. Extracellular Nicotinamide Phosphoribosyltransferase Is a Therapeutic Target in Experimental Necrotizing Enterocolitis
    Melissa D. Halpern, Akash Gupta, Nahla Zaghloul, Senthilkumar Thulasingam, Christine M. Calton, Sara M. Camp, Joe G. N. Garcia, Mohamed Ahmed · 2024 · Biomedicines
90. Innate Immunity: A Potent Target for Management of Inflammatory Bowel Disease
    Masayuki Fukata · 2012 · InTech eBooks
91. TLR ligands as immunomodulators: mechanistic insights and therapeutic potential in infectious and inflammatory diseases
    Divya Verma, Sarthak Dhar, Takhellambam Malemnganba, Sanyukta Sharma, Sramona Kar, Vijay Kumar Prajapati · 2026 · Molecular Biology Reports
92. Modulation of Lipopolysaccharide Signalling Through TLR4 Agonists and Antagonists
    Francesco Peri, Matteo Piazza, Valentina Calabrese, Roberto Cighetti · 2011 · Springer eBooks
93. Inflammatory Bowel Disease
    Nick Pullen, Jeremy D. Gale · 2007 · Elsevier eBooks
94. The TLR4 antagonist CRX-526 reduces LPS-induced leukocyte activation and improves capillary perfusion of the rat intestine
    Marieke Soltow, K Zimmermann, D. Pavlović, Juan Zhou, Sara Whynot, Orlando Ricardo Hung, M Murphy, Brent Johnston, C Lehmann · 2010 · Critical Care
95. The innate immune system as a therapeutic target in inflammatory bowel diseases
    Elke Cario, Daniel K. Podolsky · 2009 · Springer eBooks
96. Characterization of Anti-Fungal Inflammasome Responses and the Role of Caspase-8 in Innate Immune Signaling: A Dissertation
    Sandhya Ganesan · 2014 · eScholarship@UMassChan
97. The role of citrulline in patients following hematopoietic stem cell transplantation
    Alexandra H. E. Herbers · 2015 · Radboud Repository (Radboud University)
98. The expression of Toll-like receptors-2 and-4 by human crypt intestinal epithelial cells, intestinal myofibroblasts and putative intestinal stem cells in inflammatory bowel disease
    Matthew Brown · 2012 · Nottingham ePrints (University of Nottingham)
99. Participação do receptor tipo Toll 4 na reatividade vascular em ratos espontaneamente hipertensos.
    Gisele Facholi Bomfim · 2012 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
100. Role of Pattern Recognition Receptors in Modulating Intestinal Immune Responses and Potential Therapeutic Implications for Inflammatory Bowel Diseases
     Cario Elke, Daniel K. Podolsky · 2007 · Wiley eBooks